Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Wolwo Pharma(300357) the Revenue is 261.32 M (+2.17%);the EBIT is 105.54 M (-3.08%);the EPS is 0.18 (-8.21%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.26B2.17%
----
----
EBIT
0.11B3.08%
----
----
EPS
0.188.21%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf